The Brexit Health Alliance is warning that efforts to prevent the spread of infectious diseases in the UK could be under threat if the country pulls out of the EU’s early warning system without having a suitable replacement.
13th June 2018
The NHS could free up frontline time worth up to £12.5 billion a year by fully embracing automation, such as employing robots at the bed side and care bots in the home, according to a new report led by former health minister Lord Darzi.
13th June 2018
Gruenenthal has kicked off two pivotal Phase III trials investigating the bisphosphonate neridronate for the treatment of Complex Regional Pain Syndrome (CRPS).
13th June 2018
US regulators have given MSD’s Keytruda its first regulatory approval for a gynaecological cancer.
13th June 2018
Alzheimer’s disease research has taken another hit with the failure of AstraZeneca and Eli Lilly’s experimental (BACE) inhibitor lanabecestat.
12th June 2018
Cancer Research UK has begun testing a novel immunotherapy vaccine for lung cancer in Phase I trials, under a collaboration agreement with Asterias Biotherapeutics.
12th June 2018
The Scottish Medicines Consortium has approved NHS funding for six new therapies, offering patients new options for leukaemia, epilepsy, lung cancer, plaque psoriasis, and carcinoid syndrome-related diarrhea.
12th June 2018
Allergan says its CGRP receptor antagonist atogepant has hit its primary target in a Phase IIb/III trial assessing its efficacy in preventing episodic migraine.
12th June 2018
An international team of researchers, led by scientists at The Institute of Cancer Research, London, are planning to trial a novel saliva-based DNA test designed to predict men at risk of developing prostate cancer.
12th June 2018
The University of Huddersfield has launched the Centre for Pharmaceutical Policy and Practice Research, tasked with keeping the industry “armed with the latest research methods and advice”.
11th June 2018
AstraZeneca’s Tagrisso has been given a green light in Europe for first-line use to treat EGFR-mutated non-small cell lung cancer (NSCLC), offering a new line of attack at this stage of the disease.
11th June 2018
US regulators have approved a combination of AbbVie and Roche’s Venclexta in combination with Roche/Biogen's Rituxan (rituximab) to treat chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL).
11th June 2018
Vertex has presented long-term, observational data highlighting the benefit of Kalydeco in patients with cystic fibrosis.
8th June 2018
Following on from Dr Jim Golby’s comments only last week, David Garmon-Jones, co-chair of the competition’s executive steering group (ESG) is also calling on all pharma sales professionals to get involved in the competition.
8th June 2018
With spaces in the Communications Team of the Year competition filling up fast, agencies are advised to act now and get their entry for the NHS Challenge in before it's too late!
8th June 2018
